Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease ; volume:9 ; number:1 ; day:29 ; month:5 ; year:2012 ; pages:1-19 ; date:12.2012
Journal of neuroinflammation ; 9, Heft 1 (29.5.2012), 1-19, 12.2012
- Urheber
-
Puli, Lakshman
- Beteiligte Personen und Organisationen
-
Pomeshchik, Yuriy
Olas, Katja
Malm, Tarja
Koistinaho, Jari
Tanila, Heikki
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-9-105
- URN
-
urn:nbn:de:1111-2016032331158
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Puli, Lakshman
- Pomeshchik, Yuriy
- Olas, Katja
- Malm, Tarja
- Koistinaho, Jari
- Tanila, Heikki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation
Neuroinflammation and fractalkine signaling in Alzheimer’s disease
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Intravenous immunoglobulin and Alzheimer’s disease: what now?
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation
Neuroinflammation and fractalkine signaling in Alzheimer’s disease